Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $501,075 | $352,948 | $287,063 | $458,190 |
| - Cash | $180,360 | $196,467 | $216,948 | $237,028 |
| + Debt | $21,865 | $22,933 | $42,658 | $28,550 |
| Enterprise Value | $342,580 | $179,414 | $112,773 | $249,712 |
| Revenue | $17,151 | $24,510 | $29,382 | $21,000 |
| % Growth | -30% | -16.6% | 39.9% | – |
| Gross Profit | $13,809 | $24,510 | $29,382 | $21,000 |
| % Margin | 80.5% | 100% | 100% | 100% |
| EBITDA | -$12,685 | -$10,837 | -$16,025 | -$29,190 |
| % Margin | -74% | -44.2% | -54.5% | -139% |
| Net Income | -$13,448 | -$9,180 | -$14,076 | -$30,005 |
| % Margin | -78.4% | -37.5% | -47.9% | -142.9% |
| EPS Diluted | -0.49 | -0.34 | -0.52 | -1.11 |
| % Growth | -44.1% | 34.6% | 53.2% | – |
| Operating Cash Flow | -$17,151 | -$5,755 | -$35,138 | -$284 |
| Capital Expenditures | -$181 | $0 | -$137 | $0 |
| Free Cash Flow | -$17,332 | -$5,755 | -$35,275 | -$284 |